^
BIOMARKER:

TMB-H + PD-L1 expression

i
Other names: PD-L1, CD274, HPD-L1, PD-L1, B7H1, PDL1, Programmed death ligand 1, B7-H1, B7-H, PDCD1L1, PDCD1LG1, PDCD1 Ligand 1, B7 homolog 1, CD274 Antigen, Programmed cell death 1 ligand 1, CD274 molecule
Entrez ID:
Related biomarkers:
TMB-H + PD-L1 expression
Triple Negative Breast Cancer
atezolizumab
Sensitive: B - Late Trials
TMB-H + PD-L1 expression
Urothelial Cancer
atezolizumab
Sensitive: B - Late Trials
TMB-H + PD-L1 expression
Small Cell Lung Cancer
atezolizumab
Sensitive: C3 – Early Trials
TMB-H + PD-L1 expression
Urothelial Cancer
durvalumab + CP-675206
Sensitive: C3 – Early Trials
TMB-H + PD-L1 expression
Urothelial Cancer
nivolumab
Sensitive: C3 – Early Trials
TMB-H + PD-L1 expression
NSCLC
Immunotherapy
Sensitive: C3 – Early Trials
TMB-H + PD-L1 expression
CRC
nivolumab + TAS-116
Sensitive: C3 – Early Trials
TMB-H + PD-L1 expression
NSCLC
anlotinib + sintilimab
Sensitive: C3 – Early Trials
TMB-H + PD-L1 expression
Penile Cancer
toripalimab
Sensitive: C4 – Case Studies
TMB-H + PD-L1 expression
Squamous Cell Skin Cancer
pembrolizumab + panitumumab
Sensitive: C4 – Case Studies
TMB-H + PD-L1 expression
Urothelial Cancer
pembrolizumab
Sensitive: C4 – Case Studies